Navigation Links
InterMune Reports First Quarter 2009 Financial Results and Business Highlights
Date:4/30/2009

after the call.

To access the webcast, please log on to the company's website at www.intermune.com at least 15 minutes prior to the start of the call to ensure adequate time for any software downloads that may be required.

The teleconference replay will be available approximately three hours after the call. The teleconference replay will be available for 10 business days following the call and can be accessed by dialing 800-642-1687 (U.S.) or 706-645-9291 (international), and entering the conference ID# 95970767. The webcast will remain available on the company's website until the next earnings call.

About InterMune

InterMune is a biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and hepatology. InterMune has an R&D portfolio addressing idiopathic pulmonary fibrosis (IPF) and hepatitis C virus (HCV) infections. The pulmonology portfolio includes pirfenidone for which a Phase 3 program in patients with IPF (CAPACITY) has been completed and the compound is currently in the pre-registration stage. The company also has a research program focused on a pirfenidone analog named ITMN-520. The hepatology portfolio includes the HCV protease inhibitor compound ITMN-191 (referred to as R7227 at Roche) expected to enter Phase 2b in the summer of 2009 and a second-generation HCV protease inhibitor research program. For additional information about InterMune and its R&D pipeline, please visit www.intermune.com.

Forward-Looking Statements

This news release contains forward-looking statements within the meaning of section 21E of the Securities Exchange Act of 1934, as amended, that reflect InterMune's judgment and involve risks and uncertainties as of the date of this release, including without lim
'/>"/>

SOURCE InterMune, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. InterMune to Release First Quarter Financial Results on April 30
2. InterMune and Pharmasset to Discuss INFORM-1 Results From EASL Conference, April 25
3. InterMune to Present at Canaccord Adams Hepatitis C Conference
4. InterMune to Present at Citis 4th Annual Biotech Day
5. InterMune to Present Abstracts on HCV Protease Inhibitor ITMN-191 and HCV Development Program at the EASL Meeting
6. InterMune Reports Fourth Quarter and Full Year 2008 Financial Results and Business Highlights
7. InterMune to Release Fourth Quarter, Full Year 2008 Financial Results on February 26
8. InterMune Announces Issuance of U.S. Patent for ITMN-191
9. InterMune Announces Pricing of Public Offering of 3,500,000 Shares of Common Stock
10. InterMune Reports Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF
11. InterMune to Present at J.P. Morgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... Emerson Resources Inc. , a premier ... the Company’s Chief Executive Officer and Chairman of the ... of service. As part of Emerson Resources’ planned leadership ... named as Dr. Signorino’s successor. , Dr. Signorino ... made a significant contribution to the field during his ...
(Date:5/21/2013)... , May 21, 2013  Synthetic Biologics, Inc. (NYSE ... and treatment of serious infectious diseases, announced today that ... 2 nd Annual Marcum LLP MicroCap Conference on Thursday, ... at the Grand Hyatt Hotel. Mr. Riley is scheduled ... live webcast of Synthetic Biologics, presentation can be accessed by ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Bed bugs have ... to My Cleaning Products, many turn to chemical-based pesticides for ... the health and environmental risks those solutions present, the company ... Bed Bug Bully instead. , According to My Cleaning ... as they used to be. It shared that the pests ...
(Date:5/21/2013)... NANONEX CORPORATION, a pioneer and leading company in ... delivery and installation of a new nanoimprint lithography ... Japanese manufacturing company. , Nanonex’s ... tool that has the ability to process a ... Based on Nanonex inventions and proprietary technologies, including ...
Breaking Biology Technology:Emerson Resources Announces CEO Retirement and Appointment of Successor 2Emerson Resources Announces CEO Retirement and Appointment of Successor 3Synthetic Biologics to Present at the 2nd Annual Marcum LLP MicroCap Conference 2New Guide to Kill Bed Bugs Published by My Cleaning Products, Company Enumerates Non-Toxic Means to Clear the Pests 2New Guide to Kill Bed Bugs Published by My Cleaning Products, Company Enumerates Non-Toxic Means to Clear the Pests 3Nanonex Announces the Shipment and Installation of an Innovative Nanoimprint Lithography System for Fully Automated Manufacturing 2
... Anesiva,Inc. (Nasdaq: ANSV ) announced today the ... directors. Mr. Janney previously served on Anesiva,s,board from November ... following the merger of Anesiva and AlgoRx Pharmaceuticals., ... of directors,and we are very pleased to welcome him ...
... Inc.,today announced that Edward L. Jacobs, president and ... medical officer,will present an update of the company,s ... Feb. 13, 2008, at the BIO CEO & ... will include information about Semafore,s lead product,candidate, SF1126, ...
... Diagnostic Imaging,International Corp. (OTCBB: DIIG) announced today that ... imaging clinics for acquisition., Following the Company,s ... of profitable operating clinics as well as open ... begun its diligence review on clinics that have,been ...
Cached Biology Technology:Anesiva Appoints Daniel Janney to Board of Directors 2Anesiva Appoints Daniel Janney to Board of Directors 3Semafore to Present at BIO CEO & Investor Conference 2Diagnostic Imaging - Acquisitions - OTCBB: DIIG 2
(Date:5/17/2013)... noise of the South, but the night belongs to the ... heavy from the humidity and the sounds of wildlife. ... frogs, toads and salamanders, is the center of amphibian biodiversity ... the auditorium for their symphonic choruses, the scientists of the ... have front-row seats. , Amphibians, which rely on ...
(Date:5/17/2013)... ages will celebrate the science and technology of ... lives during the inaugural Atlanta Science Festival, March ... local museums, corporations, K-12 schools and universities, the ... for children and adults at venues across the ... , The annual Atlanta Science Festival is a ...
(Date:5/17/2013)... Shenzhen, China---- Why Tibetan antelope can live at ... a collaborative research published in Nature Communications ... institutes provide evidence that some genetic factors may ... highland environments. The data in this work will ... and the biology of other ruminant species. , ...
Breaking Biology News(10 mins):Front-row seats to climate change 2Front-row seats to climate change 3Front-row seats to climate change 4First Atlanta Science Festival set for 2014 2The genome sequence of Tibetan antelope sheds new light on high-altitude adaptation 2
... modeling effort has found that additional growth of plants and ... would create a new negative feedback a cooling effect ... reduce future global warming. The cooling effect would be ... degrees C (-1.1 F) over land, compared to simulations where ...
... Seattle Biomedical Research Institute (Seattle BioMed) and Northwestern University ... in the effort to wipe out some of the ... two large structural genomics centers, they,ve experimentally determined 500 ... protozoan pathogens, which could potentially lead to new drugs, ...
... Brussels, 7 December 2010 Polar research must become ... Europe is to benefit from the dramatically changing face of ... at the launch of its strategic position paper on European ... European research activities in the Polar Regions are ...
Cached Biology News:'Greener' climate prediction shows plants slow warming 2'Greener' climate prediction shows plants slow warming 3Milestone in fight against deadly disease 2Milestone in fight against deadly disease 3It's time for Europe to step up research in the polar regions 2
The Cellject Elecroporator is suitable for all cell types including embryo, mammalian, plant, yeast and bacterial. Its has highly user-freindly programing and can be used remotely, for example in a l...
... coli containing a clone of the human Topoisomerase ... II alters the topological state of nucleic acids ... transient break which generates a separate DNA helix ... DNA passage mechanism, the enzyme can relax negatively ...
Maxi XL Hybridization Oven for Extra Large bottles. 6 bottle (70 mm) rotisserie + shaker tray available for simultaneous use. Includes linear and orbital shaker trays, 4 extra large bottles, pack o...
... Cell Expansion Kit - Monolayer is a system ... as a monolayer in a serum-free environment. The ... Supplement, which has been optimized for neural stem ... (1996) Genes & Development 10 :3129). Human ...
Biology Products: